The Department provides radiation medicine to the region's oncology patients and serves as the academic infrastructure for radiation science at the UMMS.
Using image guided platforms with three-dimensional treatment simulators for treatment planning and execution, the department provides extensive brachytherapy services including all facets of genitourinary and gynecological applications to patients.
Radiation Oncology houses the IROC Rhode Island (QARC), a quality assurance vehicle and data management service for diagnostic imaging and radiation oncology for the National Cancer Institute Clinical Trials Program. Led by Dr. FitzGerald as its director and principal investigator, QARC acquires and reviews imaging and treatment objects on a pre-therapy basis to ensure compliance of treatment to protocol management for patients on clinical trials. QARC is located in Lincoln, RI.
The department has several research interests, with particular emphasis on signaling pathways and cellular adhesion molecules. Most of the targeted oncology therapies developed in the past five years include tyrosine kinase-based therapies that sensitize cancer cells to radiation therapy. Identifying the interactions between these therapies and radiation therapy is the focus of the translational research effort, with collaborations promoted through the departments of Cancer Biology and Cell Biology.
Thomas (TJ) FitzGerald, MD
Christopher Riberdy, MHA, BS, RTT
Director Radiation Oncology
UMMMG Cancer ServicesAdministrator
Executive Administrative Assistant